COVID-19 e Telepsychotherapy: Which Variables Affect Therapeutic Experience?
TELECOVID
1 other identifier
observational
71
1 country
1
Brief Summary
COVID-19 pandemic forced a widespread adoption of telemedicine, including telepsychotherapy. Telepsychotherapy has been proven to be effective before COVID-19 breakout (Poletti et al., 2020); however, both patients and therapists were skeptical about this modality. The aim of this study is to probe the experience of telepsychotherapy in both patients and therapists, during the COVID-19 lockdown. Thus, when the adoption of online colloquia was mandatory and not an option. Crucially, studying the experience of telepsychotherapy during the COVID-19 pandemic allows i) investigating also the experience of those patients and therapists that were not favorable to this kind of intervention and ii) comparing the experience of therapy in the online and face-to-face modality, in the same patients and therapists. Furthermore, we collect several psychological variables that possibly influence the experience and efficacy of telepsychotherapy (e.g., personality traits, attachment state of mind, previous traumatic experiences) to define the psychological profile behind a favorable or negative experience of telemedicine in both patients and therapists. As crucial novelty, this information is collected in both patients and their therapists, allowing the direct comparisons between the experience of the therapeutic relationship (e.g., empathy, alliance) from two different point of views. The results of the present study may help in the definition of possible subgroups of patients who may be sufficiently responsive to telepsychotherapy and those who may benefit - exclusively - of face-to-face interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedFirst Submitted
Initial submission to the registry
February 22, 2023
CompletedFirst Posted
Study publicly available on registry
February 24, 2023
CompletedFebruary 24, 2023
February 1, 2023
1.1 years
February 22, 2023
February 23, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Telepsychotherapy perception
Psychometric measures of general perception/experience on the remotely delivered psychotherapy as far as efficacy and interpersonal factors are concerned
At enrollment
Interventions
Remotely delivered psychotherapy sessions
Eligibility Criteria
The study addresses both licensed and currently practicing psychotherapists and their patients, namely individuals currently undergoing a psychotherapy
You may qualify if:
- Licensed and currently practicing psychotherapists
- Individuals currently undergoing a psychotherapy
You may not qualify if:
- not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto Auxologico Italiano
Milan, 20149, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2023
First Posted
February 24, 2023
Study Start
April 5, 2021
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
February 24, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share